Contact — Azuriya Pharma
Azuriya Pharma Contact
Contact

We Look Forward to Connecting

Azuriya Pharma welcomes inquiries from physicians, investigators, potential pharma partners, and the investor community.

We welcome inquiries

Reach us directly at [email protected], or use the form below.

By submitting this form you acknowledge Azuriya Pharma's privacy policy. We will only use your information to respond to your inquiry and will not share it with third parties.

Forward-Looking Statements

Information on this website contains forward-looking statements regarding Azuriya Pharma's clinical development plans, financing scenarios, and strategic milestones. Actual results may differ materially from those contemplated. Our program is an investigational compound and has not been approved by the FDA, EMA, or any other regulatory authority.

Privacy & Confidentiality

Azuriya Pharma does not share inquiries or contact information with third parties. Confidential materials (full investor package, data room) require execution of an NDA. For more information contact [email protected].

Azuriya Pharma

A clinical-stage, first-in-class oral small molecule for Inflammatory Bowel Disease — targeting a novel upstream regulator of inflammatory transcription factors.

Site

© 2026 Azuriya Pharma. All rights reserved. Our program is an investigational compound and has not been approved by any regulatory authority.